focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEngage Xr Regulatory News (EXR)

Share Price Information for Engage Xr (EXR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.85
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.10 (5.556%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.85
EXR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EPT Disclosure

7 May 2008 11:30

UBS AG (EPT)07 May 2008 FORM 38.5(b) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RI STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(b) of the Takeover Code) 1. KEY INFORMATION Name of exempt principal trader UBS AG London BranchCompany dealt in Expro International Group PlcClass of relevant security to which the 10p Ordinarydealings being disclosed relate (Note 1)Date of dealing 06 MAY 2008 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2) Long Short Number (%) Number (%)(1) Relevant securities 469,400 0.43% 1,468 0.00%(2) Derivatives (other thanoptions)(3) Options and agreements topurchase/sellTotal 469,400 0.43% 1,468 0.00% (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2) Class of relevant security: Long Short Number (%) Number (%)(1) Relevant securities(2) Derivatives (other thanoptions)(3) Options and agreements topurchase/sellTotal (c) Rights to subscribe (Note 2)Class of relevant security: Details 3. DEALINGS (Note 3) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 4) PURCHASE 35 1506 pence PURCHASE 75 1506 PURCHASE 132 1506 PURCHASE 165 1506 PURCHASE 165 1506 PURCHASE 315 1508 PURCHASE 699 1508 SALE 500 1511 PURCHASE 85 1511 PURCHASE 1034 1511 SALE 1690 1512 SALE 444 1514 SALE 221 1514 SALE 204 1514 SALE 93 1514 SALE 82 1514 SALE 300 1515 PURCHASE 47 1515 SALE 2793 1516 SALE 5146 1517 SALE 5000 1517 SALE 3659 1517 SALE 3659 1517 SALE 3650 1517 SALE 3650 1517 SALE 3650 1517 SALE 3500 1517 SALE 3060 1517 SALE 3000 1517 SALE 1100 1517 SALE 911 1517 SALE 860 1517 SALE 847 1517 SALE 840 1517 SALE 700 1517 SALE 200 1517 SALE 53 1517 SALE 16 1517 SALE 8000 1518 SALE 3650 1518 SALE 2580 1518 SALE 2360 1518 SALE 2360 1518 SALE 2195 1518 SALE 1999 1518 SALE 1716 1518 SALE 1544 1518 SALE 1358 1518 SALE 1350 1518 SALE 1290 1518 SALE 901 1518 SALE 897 1518 SALE 891 1518 SALE 883 1518 SALE 839 1518 SALE 835 1518 SALE 820 1518 SALE 716 1518 SALE 546 1518 SALE 467 1518 SALE 400 1518 SALE 350 1518 SALE 285 1518 SALE 250 1518 SALE 235 1518 SALE 212 1518 SALE 200 1518 SALE 200 1518 SALE 200 1518 SALE 177 1518 SALE 100 1518 SALE 100 1518 SALE 99 1518 SALE 83 1518 SALE 83 1518 SALE 65 1518 SALE 41 1518 SALE 36 1518 SALE 35 1518 SALE 31 1518 PURCHASE 45 1518 PURCHASE 350 1518 PURCHASE 396 1518 SALE 361 1519 PURCHASE 49 1519 PURCHASE 69 1519 PURCHASE 69 1519 PURCHASE 261 1519 PURCHASE 500 1519 PURCHASE 4601 1519 PURCHASE 4937 1519 PURCHASE 437 1520 PURCHASE 4934 1520 SALE 1632 1524 SALE 964 1524 SALE 566 1524 SALE 189 1524 SALE 1068 1525 SALE 203 1525 SALE 51 1525 PURCHASE 17 1525 PURCHASE 120 1525 PURCHASE 200 1525 PURCHASE 288 1525 PURCHASE 876 1525 SALE 300 1526 SALE 300 1526 PURCHASE 200 1526 PURCHASE 900 1526 PURCHASE 1140 1526 SALE 1900 1527 PURCHASE 200 1527 PURCHASE 415 1527 PURCHASE 417 1527 SALE 420 1528 SALE 340 1528 PURCHASE 42 1528 TOTAL PURCHASES 24,215 TOTAL SALES 99,501 (b) Derivatives transactions (other than options)Product name, e.g Long/short (Note 5) Number of securities Price per unitCFD (Note 6) (Note 4) (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, e.g. Expiry Optionname,e.g. selling, securities price American, date money paid/call purchasing, to which the European received peroption varying etc option etc. unit (Note relates 4) (Note 6) (ii) Exercising Product name, e.g. call Number of securities Exercise price per unitoption (Note 4) (d) Other dealings (including new securities) (Note 3) Nature of transaction Details Price per unit (if applicable)(Note 7) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. .............................................................................. .............................................................................. Is a Supplemental Form 38.5(b) attached? (Note 8) NO Date of disclosure 07 MAY 2008Contact name LOUISE ROBINSONTelephone number 020 7567 8762Name of offeree/offeror with which connected Halliburton CompanyNature of connection (Note 9) CONNECTED ADVISER Notes The Notes on Form 38.5(b) can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
23rd Apr 202412:53 pmRNSDirector/PDMR Shareholding
15th Apr 20247:00 amRNSFinal Results
28th Mar 20247:00 amRNSNotice of Results & Investor Presentation
13th Mar 20247:00 amRNSLaunch of School of AI
26th Feb 20247:00 amRNSTrading Update
23rd Feb 20247:00 amRNSHolding(s) in Company
20th Feb 20247:00 amRNSMajor Contract Wins
19th Dec 20237:00 amRNSTrading Update
8th Dec 20237:00 amRNSBoard Change
11th Sep 20237:00 amRNSInterim Results
31st Aug 20237:00 amRNSNotice of Investor Presentation
3rd Aug 20237:00 amRNSGrant of Options
1st Aug 20237:00 amRNSPre-Close Trading Update and Notice of Results
29th Jun 20232:23 pmRNSResult of AGM
7th Jun 20237:00 amRNSNotice of AGM
1st Jun 20237:00 amRNSLaunch of Lenovo’s new VR headset
23rd May 20237:00 amRNSFinal Results
12th May 20237:00 amRNSInvestor Presentation
27th Apr 20237:00 amRNSTrading Update & Notice of Results
31st Mar 20237:00 amRNSFatboy Slim concert takes place in ENGAGE Link
21st Mar 20237:00 amRNSCancellation of Admission to Euronext Growth
17th Mar 20237:00 amRNSFatboy Slim set to perform in ENGAGE
8th Mar 20231:05 pmRNSTR-1: Notification of major holdings
7th Mar 20235:30 pmRNSTR-1: Notification of major holdings
7th Mar 20232:19 pmRNSTR-1: Notification of major holdings
6th Mar 20234:50 pmRNSTR-1: Notification of major holdings
3rd Mar 202312:00 pmRNSResult of EGM
27th Feb 20233:45 pmRNSSigning of Subscription Agreement and TVR
7th Feb 202311:45 amRNSPosting of Circular
6th Feb 202312:00 pmRNS£8.8 million Placing
6th Feb 20237:00 amRNSProposed Placing of New Ordinary Shares
31st Jan 202311:05 amRNSSecond Price Monitoring Extn
31st Jan 202311:00 amRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSENGAGE showcases first AI-powered virtual employee
18th Jan 20237:00 amRNSFY2022 Trading Update and Notice of Results
12th Dec 20222:05 pmRNSSecond Price Monitoring Extn
12th Dec 20222:00 pmRNSPrice Monitoring Extension
12th Dec 202211:05 amRNSSecond Price Monitoring Extn
12th Dec 202211:00 amRNSPrice Monitoring Extension
12th Dec 20227:00 amRNSTrading Update
21st Nov 20227:00 amRNSCommercial reseller agreement signed with Lenovo
7th Nov 20227:00 amRNSLaunch of ENGAGE Link & Investor Presentation
28th Sep 202211:00 amRNSENGAGE XR to collaborate with Lenovo
21st Sep 20222:09 pmRNSHolding(s) in Company
13th Sep 20227:00 amRNSInterim Results
16th Aug 20227:00 amRNSInvestor Presentation
2nd Aug 20227:00 amRNSPre-Close Trading Update and Notice of Results
18th Jul 202211:00 amRNSDirectors’ Disclosure
23rd Jun 20227:00 amRNSENGAGE & METAVERSE UPDATE
16th Jun 202211:58 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.